Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
about
Fecal calprotectin in inflammatory bowel diseaseFaecal calprotectin: Management in inflammatory bowel diseaseCorrelation of endoscopic disease severity with pediatric ulcerative colitis activity index score in children and young adults with ulcerative colitisUpregulation of calprotectin in mild IgE-mediated ovalbumin hypersensitivity.Advances in IBS 2016: A Review of Current and Emerging Data.Occult Blood and Perianal Examination: Value Added in Pediatric Inflammatory Bowel Disease ScreeningImplementable strategies and exploratory considerations to reduce costs associated with anti-TNF therapy in inflammatory bowel diseaseFecal calprotectin use in inflammatory bowel disease and beyond: A mini-review.FOCUS: Future of fecal calprotectin utility study in inflammatory bowel disease.Noninvasive biomarkers as surrogate predictors of clinical and endoscopic remission after infliximab induction in patients with refractory ulcerative colitis.Utility of Biomarkers in the Management of Inflammatory Bowel Disease.Low Fecal Calprotectin Correlates with Histological Remission and Mucosal Healing in Ulcerative Colitis and Colonic Crohn's Disease.How to use faecal calprotectin in management of paediatric inflammatory bowel disease.Comparison of Fecal Calprotectin Methods for Predicting Relapse of Pediatric Inflammatory Bowel Disease.Utility of Fecal Calprotectin in Evaluation of Chronic Gastrointestinal Symptoms in Primary Care.Understanding and Managing IBS and CIC in the Primary Care Setting
P2860
Q26766527-F41248C4-A5C2-4088-81BC-42F4F87B4A9EQ26776145-EED708C2-0EF1-48DF-80AF-685462A2A3E7Q33696416-A9254B13-E964-4D05-8429-0806E70486CCQ33913941-F4E7CA9F-41F4-40B6-A8A3-9F05629DA072Q36245061-097ECE3D-F29B-42EA-AA1C-B5AC21469E8DQ36531373-F314E5ED-0553-42DC-8823-E11F436ED833Q37719806-251F549A-2581-4F2E-9A0C-021810F63700Q38412474-7E9C50B9-A2CA-43EE-BC7A-FDB7673E6701Q38816111-DECD7F5D-7184-4CBA-8FC7-CEAE8D724EEDQ39053285-41ECBDC5-5CA8-4E6E-B20A-72BDEC2EDC63Q39110763-BED7250A-A4F7-4696-9EC3-E8211E9213B4Q40038096-A136B7A8-E8B2-46D7-B615-7D8793DAA604Q40803974-EC84183E-5BD5-4B18-9E95-3D7173B0F764Q41928544-05732A00-20A8-4E23-99BD-5A264980EFFEQ47344204-2FBA1424-B337-4CBC-93F5-4423777A1D35Q57145627-0631E923-768E-4591-B060-BAC9E74A9711
P2860
Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 21 July 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Effectiveness and cost-effecti ...... isease in adults and children.
@en
Effectiveness and cost-effecti ...... isease in adults and children.
@nl
type
label
Effectiveness and cost-effecti ...... isease in adults and children.
@en
Effectiveness and cost-effecti ...... isease in adults and children.
@nl
prefLabel
Effectiveness and cost-effecti ...... isease in adults and children.
@en
Effectiveness and cost-effecti ...... isease in adults and children.
@nl
P2860
P921
P1476
Effectiveness and cost-effecti ...... isease in adults and children.
@en
P2093
P2860
P304
P356
10.1016/J.CGH.2013.06.028
P407
P50
P577
2013-07-21T00:00:00Z